A 55 years old male patient, who is planned for bronchoscopy developed central anti-cholinergic syndrome due to therapeutic dose of atropine. Withdrawal of atropine has improved the symptoms. Thereafter, instillation of atropine as eye drops leads to reappearance of symptoms. The reaction was definite according to Naranjo's algorithm. It was severe and definitely preventable according to Modified Hartwig and Siegel's scale and Modified Schumock and Thornton scale respectively. Central anti-cholinergic syndrome may be due to variation in the genetic susceptibility (Idiosyncrasy) to atropine. Idiosyncratic reaction on administration of atropine as a pre-anesthetic medication or eye drops should be kept in mind while prescribing.

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488612800492799DOI Listing

Publication Analysis

Top Keywords

central anti-cholinergic
12
anti-cholinergic syndrome
12
therapeutic dose
8
dose atropine
8
eye drops
8
atropine
6
syndrome induced
4
induced single
4
single therapeutic
4
atropine years
4

Similar Publications

Purpose: To evaluate dynamic changes in ciliary parameters and Implantable Collamer Lens V4C (ICL) (STAAR Surgical) haptic position using mydriatic and miotic agents and their effects on the central and peripheral vault.

Methods: This study involved 80 eyes from 40 consecutive patients (mean age: 28.05 years; range: 19 to 42 years) examined 3 months after ICL implantation.

View Article and Find Full Text PDF

Background: Studies that report an association between anticholinergic medications and dementia often suffer from confounding by indication and rarely consider gender effects. We estimated the association between recurrent prescriptions for anticholinergic overactive bladder (OAB) medications and incident dementia, separately in men and women.

Method: We studied patients aged ≥50 years first prescribed an anticholinergic OAB drug (e.

View Article and Find Full Text PDF

Late blight, caused by , is a devastating disease of potato. Our previous work illustrated that scopolamine, the main bioactive substance of extract, exerts direct inhibitory effects on , but it is unclear whether scopolamine and extract can boost resistance to late blight in potato. In this study, .

View Article and Find Full Text PDF

The protective effect of the vagus nerve-α7nAChR-IL-22 pathway on acute liver injury.

Cytokine

December 2024

Department of Hepatobiliary & Hydatid Disease, Digestive & Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China; State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China. Electronic address:

Article Synopsis
  • The study investigates the role of the vagus nerve's α7nAChR receptor in regulating interleukin-22, which may help mitigate acute liver injury.
  • Carbon tetrachloride was used to induce liver injury in rat models and human liver cells, revealing that interfering with α7nAChR leads to higher liver damage markers like AST and ALT.
  • The findings suggest that enhancing vagus nerve activity and interleukin-22 levels can aid liver recovery, while blocking these pathways may worsen liver injury.
View Article and Find Full Text PDF

Diabetic gastroparesis (DGP), a prevalent complication of diabetes, is characterized by delayed gastric emptying and inflammation. The dorsal motor nucleus of the vagus (DMV) plays a crucial role in modulating gastric function via the vagus nerve. Neuregulin 1 (NRG1), which is present in the DMV and influences the autonomic nervous system, has an unclear role in DGP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!